Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Moffett

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Frontiers in Neuroenergetics|January 15, 2014
N-Acetylaspartate reductions in brain injury: impact on post-injury neuroenergetics, lipid synthesis, and protein acetylationJohn R Moffett, Peethambaran Arun, Prasanth S Ariyannur, et al.
Journal of Neurochemistry|September 2, 2006
Regulation of N-acetylaspartate and N-acetylaspartylglutamate biosynthesis by protein kinase activatorsPeethambaran Arun, Chikkathur N Madhavarao, John R Moffett, et al.
Journal of Neurochemistry|July 18, 2008
Antipsychotic drugs increase N-acetylaspartate and N-acetylaspartylglutamate in SH-SY5Y human neuroblastoma cellsPeethambaran Arun, Chikkathur N Madhavarao, John R Moffett, et al.
The Journal of Biological Chemistry|May 10, 2012
Effects of N-acetylaspartylglutamate (NAAG) peptidase inhibition on release of glutamate and dopamine in prefrontal cortex and nucleus accumbens in phencyclidine model of schizophreniaDaiying Zuo, Tomasz Bzdega, Rafal T Olszewski, et al.
Frontiers in Physiology|December 7, 2020
Acetate Revisited: A Key Biomolecule at the Nexus of Metabolism, Epigenetics and Oncogenesis-Part 1: Acetyl-CoA, Acetogenesis and Acyl-CoA Short-Chain SynthetasesJohn R Moffett, Narayanan Puthillathu, Ranjini Vengilote, et al.
Frontiers in Physiology|December 11, 2020
Acetate Revisited: A Key Biomolecule at the Nexus of Metabolism, Epigenetics, and Oncogenesis - Part 2: Acetate and ACSS2 in Health and DiseaseJohn R Moffett, Narayanan Puthillathu, Ranjini Vengilote, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 9, 2005
Progress toward acetate supplementation therapy for Canavan disease: glyceryl triacetate administration increases acetate, but not N-acetylaspartate, levels in brainRaji Mathew, Peethambaran Arun, Chikkathur N Madhavarao, et al.
Progress in Neurobiology|February 6, 2007
N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiologyJohn R Moffett, Brian Ross, Peethambaran Arun, et al.
Neurotoxicity Research|July 2, 2003
Studies on neuronal apoptosis in primary forebrain cultures: neuroprotective/anti-apoptotic action of NR2B NMDA antagonistsJitendra R Dave, Anthony J Williams, John R Moffett, et al.
Neurotoxicity Research|July 2, 2003
Down regulation of sodium channel Na(v)1.1 expression by veratridine and its reversal by a novel sodium channel blocker, RS100642, in primary neuronal culturesJitendra R Dave, Changping Yao, John R Moffett, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Frontiers in Neuroenergetics|January 15, 2014
N-Acetylaspartate reductions in brain injury: impact on post-injury neuroenergetics, lipid synthesis, and protein acetylationJohn R Moffett, Peethambaran Arun, Prasanth S Ariyannur, et al.
Journal of Neurochemistry|September 2, 2006
Regulation of N-acetylaspartate and N-acetylaspartylglutamate biosynthesis by protein kinase activatorsPeethambaran Arun, Chikkathur N Madhavarao, John R Moffett, et al.
Journal of Neurochemistry|July 18, 2008
Antipsychotic drugs increase N-acetylaspartate and N-acetylaspartylglutamate in SH-SY5Y human neuroblastoma cellsPeethambaran Arun, Chikkathur N Madhavarao, John R Moffett, et al.
The Journal of Biological Chemistry|May 10, 2012
Effects of N-acetylaspartylglutamate (NAAG) peptidase inhibition on release of glutamate and dopamine in prefrontal cortex and nucleus accumbens in phencyclidine model of schizophreniaDaiying Zuo, Tomasz Bzdega, Rafal T Olszewski, et al.
Frontiers in Physiology|December 7, 2020
Acetate Revisited: A Key Biomolecule at the Nexus of Metabolism, Epigenetics and Oncogenesis-Part 1: Acetyl-CoA, Acetogenesis and Acyl-CoA Short-Chain SynthetasesJohn R Moffett, Narayanan Puthillathu, Ranjini Vengilote, et al.
Frontiers in Physiology|December 11, 2020
Acetate Revisited: A Key Biomolecule at the Nexus of Metabolism, Epigenetics, and Oncogenesis - Part 2: Acetate and ACSS2 in Health and DiseaseJohn R Moffett, Narayanan Puthillathu, Ranjini Vengilote, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 9, 2005
Progress toward acetate supplementation therapy for Canavan disease: glyceryl triacetate administration increases acetate, but not N-acetylaspartate, levels in brainRaji Mathew, Peethambaran Arun, Chikkathur N Madhavarao, et al.
Progress in Neurobiology|February 6, 2007
N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiologyJohn R Moffett, Brian Ross, Peethambaran Arun, et al.
Neurotoxicity Research|July 2, 2003
Studies on neuronal apoptosis in primary forebrain cultures: neuroprotective/anti-apoptotic action of NR2B NMDA antagonistsJitendra R Dave, Anthony J Williams, John R Moffett, et al.
Neurotoxicity Research|July 2, 2003
Down regulation of sodium channel Na(v)1.1 expression by veratridine and its reversal by a novel sodium channel blocker, RS100642, in primary neuronal culturesJitendra R Dave, Changping Yao, John R Moffett, et al.
Pageof 6